The Middle East & Africa respiratory inhalers market is expected to grow from US$ 1,541.66 million in 2022 to US$ 2,050.66 million by 2028. It is estimated to register a CAGR of 4.9% from 2022 to 2028.
Increasing Adoption of Smart Inhalers Technology is Fueling Middle East & Africa Respiratory Inhalers Market
Smart inhalers aim to help people suffering from asthma ensure they take their medication as prescribed by recording the timing and dosage on their smartphones. The data collected can be used by a clinician to verify that the prescribed treatment is working, personalize asthma reviews to focus on the root causes of worsening symptoms, and provide early warning systems that inform when to visit a clinic. This technology could shift from one-size-fits-all asthma screening and lead to fewer routine appointments. Smart inhalers benefit adults and the geriatric population, as they struggle to take the same puffs due to uneven breathing as the muscles that support breathing and the diaphragm weaken with age, preventing air from inhaling or exhaling. Smart inhalers that are equipped with sensors can be connected to conventional inhalers and help to keep track of when the medication is taken. Being Bluetooth-enabled, they can also be remotely paired with a computer or smart device, such as a phone or tablet, to transfer data from the smart inhaler automatically. Therefore, the above-mentioned applications of smart inhalers and their growing adoption are expected to provide growth opportunities to the respiratory inhalers market in the coming years.
Middle East & Africa Respiratory Inhalers Market Overview
The Middle East & Africa respiratory inhalers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022. The market is driven by a vast population base and an increase in the prevalence of respiratory diseases. The government of Saudi Arabia is promoting and offering several incentives for the domestic manufacturing of medical devices, which can drive the overall market in this country. As per the study conducted by Boehringer Ingelheim in 2018, there were more than 7,800 people with COPD in Saudi Arabia. COPD prevalence is booming in Saudi Arabia because of the rapidly expanding cases of smoking among the population. The prevalence of COPD in the Kingdom is 2.4%. In addition, the burden of asthma in Saudi Arabia is rising as the overall prevalence of asthma in children from Saudi Arabia has been reported to range from 8% to 25% based on studies conducted over the past three decades. Hence, the increasing prevalence of chronic respiratory diseases is leading the market’s growth.
Middle East & Africa Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Respiratory Inhalers Market Segmentation
The Middle East & Africa respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Middle East & Africa respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.
Based on technology, the Middle East & Africa respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Middle East & Africa respiratory inhalers market in 2022.
Based on disease indication, the Middle East & Africa respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.
Based on country, the Middle East & Africa respiratory inhalers market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Middle East & Africa respiratory inhalers market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,541.66 Million |
| Market Size by 2028 | US$ 2,050.66 Million |
| CAGR (2022 - 2028) | 4.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
The Middle East & Africa Respiratory Inhalers Market is valued at US$ 1,541.66 Million in 2022, it is projected to reach US$ 2,050.66 Million by 2028.
As per our report Middle East & Africa Respiratory Inhalers Market, the market size is valued at US$ 1,541.66 Million in 2022, projecting it to reach US$ 2,050.66 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Middle East & Africa Respiratory Inhalers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Respiratory Inhalers Market report:
The Middle East & Africa Respiratory Inhalers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Respiratory Inhalers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Respiratory Inhalers Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Respiratory Inhalers Market
